Quantitative Image Analysis Gives More Power to the Pathologist

Images courtesy of G. Méhes, University of Pécs, Hungary "As is our pathology, so is our practice... what the pathologist thinks today, the physician does tomorrow." --Sir William Osler (1849-1919)1 A woman visits her gynecologist for her annual Pap smear. The doctor takes a cervical swab and tells the patient that the results will be back in a few days. Now the woman waits and wonders, "Could I be sick, and not even know it?" The answer will come from the doctor by way of a p

Written bySusan Jenkins
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

"As is our pathology, so is our practice... what the pathologist thinks today, the physician does tomorrow."

--Sir William Osler (1849-1919)1

A woman visits her gynecologist for her annual Pap smear. The doctor takes a cervical swab and tells the patient that the results will be back in a few days. Now the woman waits and wonders, "Could I be sick, and not even know it?" The answer will come from the doctor by way of a pathologist, who specifies whether cancer is present, what kind it is, its developmental stage, and whether there's evidence of metastasis.

The majority of samples are normal; the pathologist needs to find the rare exceptions--the proverbial needle-in-the-haystack. Traditionally, the pathologist smears the collected cells onto a slide, stains them with hematoxylin and eosin (H&E), and then painstakingly examines the slide. Based on a first pass using lower magnification (~20-40x), the pathologist develops an initial ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies